Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Hong Ngoc Thuy Pham

Hong Ngoc Thuy Pham

University of New Castle ,Australia

Title: Assessment of the in vitro antibacterial and anticancer potential of crude extract and its sub-fractions prepared from Helicteres hirsuta Lour. leaves and stems

Biography

Biography: Hong Ngoc Thuy Pham

Abstract

Helicteres hirsuta Lour. (H. hirsuta) is a member of Helicteres genus of the Sterculiaceae family. This plant is widely distributed in Southeast Asian countries, and has been traditionally used as herbal medicine for the treatment of malaria and diabetes.  However, there are limited studies on its biological properties. This study aimed to investigate the in vitro antibacterial and anticancer properties of the crude extract and its two sub-fractions. The crude extract was  prepared from ultrasonic extraction (60 °C, 150 W for 25 min) of the dried leaf and stem in 40% methanol at a ratio of 3:100 (g/mL), and then freeze-dried to obtain the powder for further analysis.  The two sub-fractions were prepared from the crude extract solution by first removing methanol, then subsequently separated using hexane, and n-butanol to obtain the saponin-enriched and aqueous fractions, which were then freeze-dried for further analysis. Antibacterial activity was assessed using the disc diffusion method and measurement of MIC values. Anticancer properties against a panel of cancer cell lines in vitro were examined using MTT and CCK-8 assays. The results revealed that the saponin-enriched fractions from H. hirsuta leaves and stems showed the highest antibacterial activity against E. coli and S. lugdunensis. In addition, these saponin-enriched fractions displayed powerful anticancer activity in vitro on a range of cancer cell lines at low doses (GI50 values of 0.36-11.17 mg/mL). Interestingly, these saponin-enriched fractions exhibited potent anti-cancer activity against two primary pancreatic cancer cell lines (MIA PaCa-2 and BxPC-3), and one secondary pancreatic cancer cell line (CFPAC-1). Therefore, these saponin-enriched fractions contain major saponin components, which posess antibacterial and anticancer properties, and thus they should be identified and separated for further assessed for their potential as food components or therapetic agents.